MC13-0076 CHFR silencing and microsatellite instability as predictors of sensitivity to docetaxel and gemcitabine in colorectal cancer.

MLA

Pelosof, L., et al. “MC13-0076 CHFR Silencing and Microsatellite Instability as Predictors of Sensitivity to Docetaxel and Gemcitabine in Colorectal Cancer.” European Journal of Cancer, vol. 49, Nov. 2013, p. S33. EBSCOhost, https://doi.org/10.1016/S0959-8049(13)70182-5.

APA

Pelosof, L., Yerram, S., Ahuja, N., Delmas, A., Danilova, L., Herman, J., & Azad, N. (2013). MC13-0076 CHFR silencing and microsatellite instability as predictors of sensitivity to docetaxel and gemcitabine in colorectal cancer. European Journal of Cancer, 49, S33. https://doi.org/10.1016/S0959-8049(13)70182-5

Chicago

Pelosof, L., S. Yerram, N. Ahuja, A. Delmas, L. Danilova, J. Herman, and N. Azad. 2013. “MC13-0076 CHFR Silencing and Microsatellite Instability as Predictors of Sensitivity to Docetaxel and Gemcitabine in Colorectal Cancer.” European Journal of Cancer 49 (November): S33. doi:10.1016/S0959-8049(13)70182-5.